GH Research PLC

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$20.12+$6.88 (+51.96%)

Jun 8, 2026

52W High $24.8752W Low $11.68

Company Details

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product...

CEO

—

IPO Date

Jun 25, 2021

Website

www.ghres.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$56M

EPS (Diluted)

Free Cash Flow

-$47M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 14, 2026

FY 2025

Mar 5, 2026

Q4 2025

Mar 5, 2026

Q3 2025

Nov 6, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee